The Technical Analyst
Cerus Corp [CERS]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Cerus Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
2.44% $1.680
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 304.56 mill |
| EPS: | -0.210 |
| P/E: | -8.00 |
| Earnings Date: | May 02, 2024 |
| SharesOutstanding: | 181.28 mill |
| Avg Daily Volume: | 1.628 mill |
| RATING 2024-04-19 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -8.00 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.04x |
| Company: PE -8.00 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.512 - 1.828 ( +/- 9.46%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-12 | Green Kevin Dennis | Buy | 21 666 | Common Stock |
| 2024-03-13 | Green Kevin Dennis | Sell | 21 058 | Common Stock |
| 2024-03-14 | Green Kevin Dennis | Sell | 21 497 | Common Stock |
| 2024-03-12 | Green Kevin Dennis | Sell | 21 666 | Restricted Stock Unit |
| 2024-03-12 | Moore Carol | Buy | 11 666 | Common Stock |
| INSIDER POWER |
|---|
| 53.76 |
| Last 100 transactions |
| Buy: 4 007 373 | Sell: 1 157 608 |
Forecast:
16:00 - $1.680
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $1.680
Forecast 2: 16:00 - $1.680
Forecast 3: 16:00 - $1.680
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.680 (2.44% ) |
| Volume | 0.966 mill |
| Avg. Vol. | 1.628 mill |
| % of Avg. Vol | 59.32 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CERS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $2.31 | N/A | Active |
|---|
CERS
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Last 10 Buy Signals
Latest Press Releases
2024-04-18 08:30:00 - Press Release
Cerus Corporation To Release First Quarter 2024 Financial Results On May 2, 2024
Concord, calif.--(business wire)--cerus corporation (nasdaq: cers) announced today that its first quarter 2024 financial results will be released on thursday, may 2, 2024, after the close of the stock market. the company will host a conference call and webcast at 4:30 p.m. et that afternoon, during which management will discuss the company's financial results and provide a general business overview and outlook. to listen to the live webcast and view the presentation slides, please visit the inv.
2024-03-26 08:30:00 - Press Release
Cerus Corporation Announces Fda Approval Of Extended Shelf Life For Intercept Platelet Processing Sets – Doubling Previous Shelf Life
Concord, calif.--(business wire)--cerus corporation (nasdaq: cers) today announced that the u.s. food and drug administration (fda) has granted approval of 12-month shelf life for intercept platelet processing sets, from the date of manufacture, effective immediately. this approval extends the set shelf life by six months from the existing six-month shelf life that took effect following a set component change last year. all intercept platelet processing sets in both customer and cerus inventori.
2024-03-19 08:00:00 - Press Release
Cerus Corporation Announces Positive Topline Results For The Phase 3 Clinical Trial Of The Intercept Blood System For Red Blood Cells In Cardiovascular Surgery Patients
Concord, calif.--(business wire)--cerus corporation (nasdaq: cers) today announced positive topline results for recepi, a pivotal phase 3 clinical trial of pathogen reduced intercept red blood cells (intercept rbcs) transfused to complex cardiac surgery patients. the trial met its primary efficacy endpoint, demonstrating non-inferiority for intercept rbcs compared to conventional rbcs as measured by the incidence of acute kidney injury (aki) following transfusion of study rbcs. aki is a sensiti.
2024-03-05 16:00:00 - Press Release
Cerus Corporation Announces Fourth Quarter And Full-year 2023 Financial Results
Concord, calif.--(business wire)--cerus corporation (nasdaq: cers) today announced financial results for the fourth quarter and full year ended december 31, 2023. recent highlights include: fourth-quarter 2023 and full-year 2023 total revenue was comprised of (in thousands, except %): three months ended twelve months ended december 31, change december 31, change 2023 2022 $ % 2023 2022 $ % product revenue $ 46,768 $ 44,034 $ 2,734 6 %.
2024-02-20 08:30:00 - Press Release
Cerus Corporation To Release Fourth Quarter And Full-year 2023 Financial Results On March 5, 2024
Concord, calif.--(business wire)--cerus corporation (nasdaq: cers) announced today that its fourth quarter and full-year 2023 financial results will be released on tuesday, march 5, 2024, after the close of the stock market. the company will host a conference call and webcast at 4:30 p.m. et that afternoon, during which management will discuss the company's financial results and provide a general business overview and outlook. to listen to the live webcast and view the presentation slides, plea.
Latest News
2024-04-18 08:30:00 - Business Wire
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Inv.
2024-01-26 11:50:00 - The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood bought shares of Tesla, Ark 21Shares Bitcoin ETF, and Cerus on Thursday. Tesla shares plunged 12% on Thursday after a troublesome quarterly report.
2024-01-15 09:30:00 - The Motley Fool
3 Growth Stocks That Could Go Parabolic in 2024
Small- to mid-cap growth stocks largely struggled over the past two years. With the Federal Reserve likely to pivot on interest rates this year, this group may be poised for a trend reversal.
2023-11-02 22:52:04 - Seeking Alpha
Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript
Cerus Corporation (NASDAQ:CERS ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Jessica Hanover - Vice President of Corporate Affairs Obi Greenman - President & Chief Executive Officer Vivek Jayaraman - Chief Operating Officer Kevin Green - Chief Financial Officer Conference Call Participants Operator Good day and thank you for standing by. Welcome to Cerus Corporation Second Quarter 2023 Earnings Conference Call.
2023-11-02 18:47:15 - Zacks Investment Research
Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates
Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 per share a year ago.
2023-08-26 06:15:09 - 24/7 Wall Street
5 Stocks Wall Street and ARK's Cathie Wood Love Are Trading Under $10 With Huge Upside Potential
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
2023-08-12 06:15:55 - 24/7 Wall Street
Cathie Wood's ARK Funds Are Loading Up on These 5 Red-Hot Stocks Trading Under $10
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
2023-08-02 18:43:52 - Zacks Investment Research
Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates
Cerus (CERS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 per share a year ago.
2023-07-19 08:30:00 - Business Wire
Cerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2023 financial results will be released on Wednesday, August 2, 2023, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit th.
2023-07-15 06:04:17 - 24/7 Wall Street
5 Stocks Under $10 With Massive Upside Potential and ARK's Cathie Wood Loves Two of Them
While Most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the amount of shares they can buy.